Explanation and interpretation of pediatric blood requirement recommendations in the national health standard "Guideline for pediatric transfusion"

Rong HUANG, Qing-Nan HE, Ming-Yan HEI, Ming-Hua YANG, Xiao-Fan ZHU, Jun LU, Xiao-Jun XU, Tian-Ming YUAN, Rong ZHANG, Xu WANG, Jin-Ping LIU, Jing WANG, Zhi-Li SHAO, Ming-Yi ZHAO, Yong-Jian GUO, Xin-Yin WU, Jia-Rui CHEN, Qi-Rong CHEN, Jia GUO, Rong GUI

Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (4) : 410-416.

PDF(566 KB)
HTML
PDF(566 KB)
HTML
Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (4) : 410-416. DOI: 10.7499/j.issn.1008-8830.2507004
GUIDELINE INTERPRETATION: GUIDELINE FOR PEDIATRIC TRANSFUSION

Explanation and interpretation of pediatric blood requirement recommendations in the national health standard "Guideline for pediatric transfusion"

Author information +
History +

Abstract

In 2022, China's National Health Commission issued the health standard "Guideline for pediatric transfusion" (WS/T 795-2022), which provides guidance and recommendations on overall pediatric blood requirements, blood for exchange transfusion, and the use of irradiated red blood cells, washed red blood cells, and fresh red blood cells. This article explains the rationale and evidence base underlying these recommendations to facilitate a clearer understanding of the guideline.

Key words

Exchange transfusion / Irradiated blood component / Washed red blood cell / Fresh red blood cell / Child

Cite this article

Download Citations
Rong HUANG , Qing-Nan HE , Ming-Yan HEI , et al . Explanation and interpretation of pediatric blood requirement recommendations in the national health standard "Guideline for pediatric transfusion"[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(4): 410-416 https://doi.org/10.7499/j.issn.1008-8830.2507004

References

[1]
中华人民共和国国家卫生健康委员会法规司. 关于发布《输血相容性检测标准》等3项推荐性卫生行业标准的通告: 国卫通〔2022〕1号[EB/OL]. (2022-02-23)[2022-09-01].
[2]
Cohn CS, Delaney M, Johnson ST, et al. Technical Manual[M]. 20th ed. Bethesda: American Association of Blood Banks, 2020: 771.
[3]
Oakley FD, Woods M, Arnold S, et al. Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products[J]. Transfusion, 2015, 55(3): 563-570. DOI: 10.1111/trf.12827 .
[4]
New HV, Berryman J, Bolton-Maggs PH, et al. Guidelines on transfusion for fetuses, neonates and older children[J]. Br J Haematol, 2016, 175(5): 784-828. DOI: 10.1111/bjh.14233 .
[5]
桂嵘, 黄蓉, 杨明华, 等. 国家卫生健康行业标准《儿科输血指南》中新生儿输血的编制说明与解读[J]. 中国当代儿科杂志, 2024, 26(12): 1249-1254. PMCID: PMC11684834. DOI: 10.7499/j.issn.1008-8830.2408014 .
[6]
中华医学会儿科学分会新生儿学组, 《中华儿科杂志》编辑委员会. 新生儿高胆红素血症诊断和治疗专家共识[J]. 中华儿科杂志, 2014, 52(10): 745-748. DOI: 10.3760/cma.j.issn.0578-1310.2014.10.006 .
[7]
林园, 王嵘. 新生儿溶血病(HDN)免疫血液学试验推荐方案[J]. 中国输血杂志, 2012, 25(2): 95-100.
[8]
Girelli G, Antoncecchi S, Casadei AM, et al. Recommendations for transfusion therapy in neonatology[J]. Blood Transfus, 2015, 13(3): 484-497. PMCID: PMC4607607. DOI: 10.2450/2015.0113-15 .
[9]
Lathe GH. Exchange transfusion as a means of removing bilirubin in haemolytic disease of the newborn[J]. Br Med J, 1955, 1(4907): 192-196. PMCID: PMC2060840. DOI: 10.1136/bmj.1.4907.192 .
[10]
SPROUL A, SMITH L. Bilirubin equilibration during exchange transfusion in hemolytic disease of the newborn[J]. J Pediatr, 1964, 65: 12-26. DOI: 10.1016/s0022-3476(64)80547-3 .
[11]
Forfar JO, Keay AJ, Elliott WD, et al. Exchange transfusion in neonatal hyperbilirubinaemia[J]. Lancet, 1958, 2(7057): 1131-1137. DOI: 10.1016/s0140-6736(58)92402-4 .
[12]
Thayyil S, Milligan DW. Single versus double volume exchange transfusion in jaundiced newborn infants[J]. Cochrane Database Syst Rev, 2006(4): CD004592. DOI: 10.1002/14651858.CD004592.pub2 .
[13]
Foukaneli T, Kerr P, Bolton-Maggs PHB, et al. Guidelines on the use of irradiated blood components[J]. Br J Haematol, 2020, 191(5): 704-724. DOI: 10.1111/bjh.17015 .
[14]
Ní Loingsigh S, Flegel WA, Hendrickson JE, et al. Preventing transfusion-associated graft-versus-host disease with blood component irradiation: indispensable guidance for a deadly disorder[J]. Br J Haematol, 2020, 191(5): 653-657. PMCID: PMC9128360. DOI: 10.1111/bjh.17016 .
[15]
Schroeder ML. Transfusion-associated graft-versus-host disease[J]. Br J Haematol, 2002, 117(2): 275-287. DOI: 10.1046/j.1365-2141.2002.03450.x .
[16]
Agbaht K, Altintas ND, Topeli A, et al. Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature[J]. Transfusion, 2007, 47(8): 1405-1411. DOI: 10.1111/j.1537-2995.2007.01282.x .
[17]
Kopolovic I, Ostro J, Tsubota H, et al. A systematic review of transfusion-associated graft-versus-host disease[J]. Blood, 2015, 126(3): 406-414. DOI: 10.1182/blood-2015-01-620872 .
[18]
Hutchinson DL, Turner JH, Schlesinger ER. Persistence of donor cells in neonates after fetal and exchange transfusion[J]. Am J Obstet Gynecol, 1971, 109(2): 281-284. DOI: 10.1016/0002-9378(71)90876-3 .
[19]
Hume HA, Preiksaitis JB. Transfusion associated graft-versus-host disease, Cytomegalovirus infection and HLA alloimmunization in neonatal and pediatric patients[J]. Transfus Sci, 1999, 21(1): 73-95. DOI: 10.1016/s0955-3886(99)00067-3 .
[20]
Sanders MR, Graeber JE. Posttransfusion graft-versus-host disease in infancy[J]. J Pediatr, 1990, 117(1 Pt 1): 159-163. DOI: 10.1016/s0022-3476(05)82460-6 .
[21]
Neves JF, Marques A, Valente R, et al. Nonlethal, attenuated, transfusion-associated graft-versus-host disease in an immunocompromised child: case report and review of the literature[J]. Transfusion, 2010, 50(11): 2484-2488. DOI: 10.1111/j.1537-2995.2010.02705.x .
[22]
van Royen-Kerkhof A, Wulffraat NM, Kamphuis SS, et al. Nonlethal transfusion associated graft-versus-host disease in a severe combined immunodeficient patient[J]. Bone Marrow Transplant, 2003, 32(10): 1027-1030. DOI: 10.1038/sj.bmt.1704266 .
[23]
Ozdemir A, Gunes T, Chiang SCC, et al. A newborn with familial hemophagocytic lymphohistiocytosis complicated with transfusion associated graft versus host disease[J]. J Pediatr Hematol Oncol, 2017, 39(6): e309-e311. DOI: 10.1097/MPH.0000000000000777 .
[24]
Lee AC, Reduque LL, Luban NL, et al. Transfusion-associated hyperkalemic cardiac arrest in pediatric patients receiving massive transfusion[J]. Transfusion, 2014, 54(1): 244-254. DOI: 10.1111/trf.12192 .
[25]
Hall TL, Barnes A, Miller JR, et al. Neonatal mortality following transfusion of red cells with high plasma potassium levels[J]. Transfusion, 1993, 33(7): 606-609. DOI: 10.1046/j.1537-2995.1993.33793325059.x .
[26]
Yuan S, Goldfinger D. A readily available assay for anti-immunoglobulin A: is this what we have been waiting for?[J]. Transfusion, 2008, 48(10): 2048-2050. DOI: 10.1111/j.1537-2995.2008.01906.x .
[27]
Brown R, Nelson M, Aklilu E, et al. An evaluation of the DiaMed assays for immunoglobulin A antibodies (anti-IgA) and IgA deficiency[J]. Transfusion, 2008, 48(10): 2057-2059. DOI: 10.1111/j.1537-2995.2008.01830.x .
[28]
Chowdary P, Nair D, Davies N, et al. Anaphylactic reaction with prothrombin complex concentrate in a patient with IgA deficiency and anti-IgA antibodies[J]. Blood Coagul Fibrinolysis, 2010, 21(8): 764-765. DOI: 10.1097/MBC.0b013e3283401465 .
[29]
Luban NL, Strauss RG, Hume HA. Commentary on the safety of red cells preserved in extended-storage media for neonatal transfusions[J]. Transfusion, 1991, 31(3): 229-235. DOI: 10.1046/j.1537-2995.1991.31391165172.x .
[30]
Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice[J]. Lancet, 2007, 370(9585): 415-426. DOI: 10.1016/S0140-6736(07)61197-0 .
[31]
Wilson RF, Binkley LE, Sabo FM, et al. Electrolyte and acid-base changes with massive blood transfusions[J]. Am Surg, 1992, 58(9): 535-544.
[32]
Cappellini MD, Farmakis D, Porter J, et al. 2021 Guidelines: for the Management of Transfusion Dependent Thalassaemia (TDT) [Internet][M]. 4th ed. Nicosia (Cyprus): Thalassaemia International Federation, 2023.

Footnotes

所有作者均声明无利益冲突。

PDF(566 KB)
HTML

Accesses

Citation

Detail

Sections
Recommended

/